We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanoparticle-Based Hydrogel Liquefies Under Pressure for Delivery by Syringe

By LabMedica International staff writers
Posted on 04 Mar 2015
A hydrogel that liquefies under pressure but reforms as a gel when the pressure is released has been recruited as a delivery system for both hydrophobic and hydrophilic anticancer agents.

Investigators at the Massachusetts Institute of Technology (Cambridge, USA) created the hydrogel by mixing PEG-PLA (polyethylene glycol- polymerized lactic acid) nanoparticles with polymeric cellulose. More...
Each polymer chain formed weak bonds with a number of nanoparticles, producing a loosely woven lattice of polymers and nanoparticles. As each attachment point was fairly weak, the bonds disassociated under the mechanical stress of being injected through a syringe. Once the shear forces had abated, the polymers and nanoparticles formed new attachments with different partners, returning the conglomerate to the gel form.

The composition of the gel allowed it to be loaded simultaneously with two different types of drugs. The PEG-PLA nanoparticles had an inner core capable of carrying small-molecule hydrophobic drugs, which include many chemotherapy agents. At the same time, the cellulose polymer, which existed in aqueous solution, could transport hydrophilic molecules such as proteins, including antibodies and growth factors.

A detailed description of the hydrogel as well as results of an in vivo experiment in which gels injected under the skin of mice survived and successfully released two drugs—one hydrophobic and one hydrophilic—over a period of several days, was published in the February 19, 2015, online edition of the journal Nature Communications.

“We are working with really simple materials,” said contributing author Dr. Mark Tibbitt, a postdoctoral researcher at the Massachusetts Institute of Technology. “They do not require any advanced chemical functionalization. Now you have a gel that can change shape when you apply stress to it, and then, importantly, it can re-heal when you relax those forces. That allows you to squeeze it through a syringe or a needle and get it into the body without surgery.”

Related Links:

Massachusetts Institute of Technology



New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Portable Electronic Pipette
Mini 96
New
Gel Cards
DG Gel Cards
New
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Over 100 new epigenetic biomarkers may help predict cardiovascular disease risk (Photo courtesy of 123RF)

Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk

Cardiovascular disease is a leading cause of death worldwide, yet predicting individual risk remains a persistent challenge. Traditional risk factors, while useful, do not fully capture biological changes... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.